|View printer-friendly version|
|Array BioPharma to Present at the Susquehanna Healthcare Conference|
|BOULDER, Colo., Mar 03, 2008 (BUSINESS WIRE) -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief
Medical Officer, John Yates, MD, will speak at the Susquehanna
Financial Group Second Annual SIGnificant Options in Healthcare
Conference on March 4 in New York City. The public is welcome to
participate in the conference through a webcast on the Array BioPharma
website, which will be available on Friday, March 7.
Event: Susquehanna Financial Group Second Annual SIGnificant
Options in Healthcare Conference
About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer, inflammatory diseases and pain. Our proprietary drug development pipeline includes clinical candidates that are designed to regulate therapeutically important target proteins and are aimed at significant unmet medical needs. In addition, leading pharmaceutical and biotechnology companies collaborate with Array to discover and develop drug candidates across a broad range of therapeutic areas. For more information on Array, please go to www.arraybiopharma.com.
SOURCE: Array BioPharma Inc.
Array BioPharma Inc.